GlassScriptPhysician profile
Alisha R Lorren
NPI 1376208249
$1,187.83
in general payments reported to CMS, 2019-2025
13 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $365 · 2023: $231 · 2024: $247 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $315.91 | 2022-2024 | Monterey Al |
| Smith+Nephew, INC. | $146.53 | 2022-2025 | Stravix, Pico 14, Renasys Touch |
| Globus Medical, INC. | $132.31 | 2023-2025 | Reline, Acp, Monument |
| Pacira Pharmaceuticals Incorporated | $106.35 | 2023-2025 | Exparel, Iovera, Zilretta |
| Abbvie INC. | $102.97 | 2023 | |
| Medtronic, INC. | $101.86 | 2023-2025 | Powerease Instruments, Centerpiece Plate Fixation System, Infinity Occipitocervical Upper Thoracic System |
| Orthofix Medical, INC. | $78.27 | 2022-2024 | Physio-Stim |
| Depuy Synthes Sales INC. | $67.60 | 2023-2024 | Synfix Evolution, Viper, Monovisc |
| Ferring Pharmaceuticals INC. | $40.92 | 2024-2025 | Euflexxa |
| Si-Bone, INC. | $35.54 | 2022-2025 | |
| Vericel Corporation | $24.04 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.09 | 2025 | |
| Heron Therapeutics, INC. | $15.44 | 2025 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alisha Lorren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.